Let's Discuss Health Group for Physician-Patient Relationship

Centre intégré de cancérologie de Laval, Laval, Canada
Physician-Patient Relationship+6 More ConditionsLet's Discuss Health Group - Behavioral
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial aims to improve communication between cancer patients and their caregivers, reduce psychological distress and help patients better understand their treatments to reduce health costs and improve outcomes. #cancer #communication #caregivers #patient

Eligible Conditions
  • Physician-Patient Relationship
  • Psychological Distress
  • Patient Engagement
  • Prostate Cancer
  • Treatment Compliance
  • Men
  • Communication

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

7 Primary · 12 Secondary · Reporting Duration: At the end of the study, up to 1.5 years

Year 5
Qualitative patient appreciation of the use of Let's Discuss Health
Radiation oncologist appreciation of Let's Discuss Health implementation in clinical routines in radiation oncology
Baseline (0 week)
Dialogic rate in the exchanges during the initial patient-radiation oncologist encounter
Frequency of themes discussed during the initial patient-radiation oncologist encounter
Patient recall of information after the initial encounter
Preponderance of initiative in the discussion during the initial patient-radiation oncologist encounter
Week 5
Adherence to the care pathway
Month 8
Change in emotional distress following the medical encounter
Intensity of symptoms during the care trajectory
Number of problems related to the cancer during the care trajectory
Patient appreciation of the use of the Let's Discuss Health website
Patient perception of the quality of the communication with the radiation oncologist
Patient use of Let's Discuss Health tools
Pre-consultation patient emotional distress during the care trajectory
Radiation oncologist's perception of the quality of the consultation
Up to 5 months
Dialogic rate of the conversations during the end-of-treatment patient-radiation oncologist encounter
Frequency of themes discussed during the end-of-treatment patient-radiation oncologist encounter
Patient recall of information after the end-of-treatment encounter
Preponderance of initiative in the discussion during the end-of-treatment patient-radiation oncologist encounter

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Usual Care Group
1 of 2
Let's Discuss Health Group
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Let's Discuss Health Group · No Placebo Group · N/A

Let's Discuss Health Group
Behavioral
Experimental Group · 1 Intervention: Let's Discuss Health Group · Intervention Types: Behavioral
Usual Care GroupNoIntervention Group · 1 Intervention: Usual Care Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at the end of the study, up to 1.5 years

Who is running the clinical trial?

CHU de Quebec-Universite LavalOTHER
157 Previous Clinical Trials
103,453 Total Patients Enrolled
Ciusss de L'Est de l'Île de MontréalLead Sponsor
60 Previous Clinical Trials
4,097 Total Patients Enrolled
Hopital Cité de la SantéUNKNOWN
Marie-Thérèse Lussier, MD, MScPrincipal InvestigatorCentre de Recherche du Centre Hospitalier de l'Université de Montréal
Marie-Andrée Fortin, MDPrincipal InvestigatorCentre intégré de cancérologie de Laval
1 Previous Clinical Trials

Eligibility Criteria

Age 18+ · Male Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are adept with the Internet.
You exhibit proficiency in the French language, capable of comprehending, conversing and reading.

Frequently Asked Questions

What is the current enrollment of this experiment?

"Affirmative. The information on clinicaltrials.gov confirms that this medical trial is recruiting patients and was initially posted on 3rd October 2021. Its most recent update occurred 24th March 2023 and 300 individuals need to be enrolled from three different sites." - Anonymous Online Contributor

Unverified Answer

Is this medical experiment currently enrolling participants?

"Data found on clinicaltrials.gov reveals that this medical trial is presently recruiting patients and has been since 3/10/2021, with the last update to the listing being made on 3/24/2023." - Anonymous Online Contributor

Unverified Answer

What goals does this clinical trial aspire to accomplish?

"This clinical trial is estimated to run for up to 5 months and aims to measure the adherence of patients to their designated care pathway. Secondary outcomes include gauging patient appreciation of the Let’s Discuss Health website by employing a 4-point Likert scale, evaluating radiation oncologist perception regarding communication quality with ratings from 0-10, as well as determining frequency of themes discussed during initial meetings via Medicode's medical interview coding system." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.